Skip to content

Exploring the mechanism of action of Yiqi Yangyin Liyan formula in the treatment of IgA nephropathy with chronic pharyngitis from pharyngeal flora-mucosal immunity-Gd-IgA1

Exploring the mechanism of action of Yiqi Yangyin Liyan formula in the treatment of IgA nephropathy with chronic pharyngitis from pharyngeal flora-mucosal immunity-Gd-IgA1

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084670
Enrollment
Unknown
Registered
2024-05-22
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgA nephropathy

Interventions

treatment group:Basic treatment combined with Yiqi Yangyin Liyan formula
control group:Basic treatment combined with Yiqi Yangyin Liyan formula simulant
healthy control group:None

Sponsors

Xiyuan Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? Previous biopsy by renal puncture is consistent with the diagnosis of IgA nephropathy; ? Chronic pharyngitis; ? 24h urine protein quantification>0.5g, =2.0g; ? eGFR>60ml/min/1.73m2; ? TCM evidence of deficiency of qi and yin; ? Age 18-65 years old; ? No antibiotics or microecological regulators were taken (or used) in the three months prior to enrollment; ? Subjects agreed and signed an informed consent form.

Exclusion criteria

Exclusion criteria: ? Combined major systemic diseases such as cardio-cerebral vascular system, nervous system and immune system; ? Used glucocorticosteroids and immunosuppressants in the last 1 month; ? Allergic or allergic to the known components of the test drug; ? Pregnant or preparing for pregnancy and breastfeeding women; ? Have participated in clinical trials of other drugs within the last 1 month; ? Psychiatric patients and those with intellectual or speech disabilities; ? Alcoholics and drug abusers and addicts.

Design outcomes

Secondary

MeasureTime frame
Interleukin;transforming growth factor-ß;B-cell-activating factor;a proliferation-inducing ligand;Urine protein quantification at 24 hours;Urine red blood cell count;blood biochemical;IgA-IgG complex;Urine Gd-IgA1/urine creatinine;

Primary

MeasureTime frame
pharyngeal flora;T-lymphocyte subset;B lymphocyte;Plasma Gd-IgA1;

Countries

China

Contacts

Public ContactLiang Ying

Xiyuan Hospital, China Academy of Chinese Medical Sciences

liangwork@126.com+86 138 1029 4660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026